Profile data is unavailable for this security.
About the company
J.G.Chemicals Limited is engaged in the business of manufacturing of zinc oxide and allied product. The Company’s product caters to a spectrum of industrial applications, including in the rubber (tire and other rubber products), ceramics, paints and coatings, pharmaceuticals and cosmetics, electronics and batteries, agro-chemicals and fertilizers, specialty chemicals, lubricants, oil and gas and animal feed. The installed capacity of its Naidupeta Facility specified above, has recently been augmented by an additional 13,440 metric tons per annum (MTPA) for zinc oxide and 10,080 MTPA for zinc sulphate and other allied chemicals. It procures its raw materials from multiple domestic and global suppliers. Its primary raw materials are virgin zinc metal and Zinc Dross (which is a type of zinc scrap). It has three manufacturing facilities at Belur and Jangalpur, located in Kolkata district, West Bengal and at Naidupeta, located in Nellore district, Andhra Pradesh.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2001
- Employees56.00
- LocationJG Chemicals Ltd34A Metcalfe StreetKOLKATA 700091IndiaIND
- Phone+91 3 344150100
- Fax+91 3 340140199
- Websitehttps://www.jgchem.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bajaj Healthcare Ltd | 4.76bn | -133.27m | 11.38bn | 944.00 | -- | -- | 77.32 | 2.39 | -4.82 | -10.30 | 172.62 | -- | -- | -- | -- | 5,041,608.00 | -- | 7.67 | -- | 14.11 | 48.43 | 33.26 | -2.80 | 7.99 | -- | 1.74 | -- | 4.90 | -26.69 | 5.04 | -122.55 | -- | 15.08 | -- |
| Ngl Fine Chem Ltd | 3.58bn | 420.29m | 12.21bn | 390.00 | 29.06 | -- | 31.67 | 3.41 | 68.03 | 68.03 | 580.00 | -- | -- | -- | -- | 9,188,328.00 | -- | 15.06 | -- | 19.58 | 52.02 | 43.53 | 11.73 | 13.15 | -- | 26.59 | -- | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
| Bliss GVS Pharma Ltd | 8.00bn | 634.20m | 13.01bn | 831.00 | 20.79 | 1.29 | 13.06 | 1.63 | 5.94 | 5.94 | 75.55 | 96.05 | 0.6454 | 3.10 | 1.98 | 9,628,987.00 | 5.80 | 6.46 | 7.04 | 8.22 | 50.26 | 43.91 | 8.99 | 9.92 | 3.74 | -- | 0.0825 | 7.92 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
| JG Chemicals Ltd | -100.00bn | -100.00bn | 13.44bn | 56.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -14.90 | -- | -43.84 | -- | -- | -- |
| Lincoln Pharmaceuticals Ltd | 5.92bn | 979.63m | 13.62bn | 1.70k | 13.90 | -- | 12.46 | 2.30 | 48.91 | 48.91 | 295.69 | -- | -- | -- | -- | 3,483,600.00 | -- | 13.95 | -- | 16.54 | 51.92 | 50.65 | 16.54 | 14.71 | -- | 60.93 | -- | 3.44 | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
| Kopran Ltd | 6.37bn | 592.79m | 13.84bn | 358.00 | 19.77 | -- | 19.01 | 2.17 | 14.53 | 14.53 | 150.01 | -- | -- | -- | -- | 17,794,040.00 | -- | 8.47 | -- | 12.23 | 36.03 | 32.93 | 9.31 | 8.89 | -- | 27.17 | -- | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
| Jagsonpal Pharmaceuticals Ltd | 2.27bn | 243.00m | 14.37bn | 1.03k | 60.46 | 7.29 | 50.38 | 6.34 | 8.98 | 8.98 | 83.78 | 74.42 | 0.9703 | 5.13 | 9.92 | 2,213,181.00 | 10.39 | 10.95 | 12.40 | 13.29 | 58.16 | 58.13 | 10.71 | 9.21 | 2.60 | 32.84 | 0.0474 | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
| Remus Pharmaceuticals Ltd | 2.12bn | 215.37m | 15.42bn | 48.00 | 70.08 | 17.75 | 57.37 | 7.26 | 37.34 | 37.34 | 374.91 | 147.42 | 1.46 | 7.61 | 3.56 | 44,270,750.00 | 17.80 | -- | 44.48 | -- | 22.67 | -- | 12.22 | -- | 1.12 | 55.56 | 0.0997 | -- | 371.94 | -- | 153.29 | -- | -- | -- |
| Zota Health Care Ltd | 1.98bn | -242.34m | 16.03bn | 445.00 | -- | -- | 3,431.57 | 8.09 | -9.27 | -9.27 | 76.32 | -- | -- | -- | -- | 4,452,605.00 | -- | -1.38 | -- | -1.85 | 49.86 | 35.95 | -12.23 | -1.33 | -- | -2.87 | -- | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Sigachi Industries Ltd | 4.10bn | 594.65m | 16.44bn | 991.00 | 30.75 | -- | 23.11 | 4.01 | 1.60 | 1.60 | 10.97 | -- | -- | -- | -- | 4,136,886.00 | -- | 14.77 | -- | 19.57 | 52.33 | 50.30 | 14.43 | 14.92 | -- | 7.19 | -- | 1.61 | 32.08 | 25.34 | 31.34 | 24.64 | 70.35 | -- |
| Beta Drugs Ltd | 2.96bn | 364.37m | 18.43bn | 371.00 | 50.57 | 11.73 | 39.86 | 6.23 | 37.90 | 37.90 | 307.59 | 163.43 | 1.31 | 4.51 | 4.17 | 7,970,723.00 | 16.10 | 15.10 | 23.91 | 22.23 | 38.73 | 39.77 | 12.32 | 12.38 | 1.51 | 17.81 | 0.0654 | 0.00 | 30.21 | 35.01 | 18.62 | 35.29 | -10.89 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Carnelian Asset Management & Advisors Pvt Ltd.as of 30 Jun 2024 | 694.64k | 1.77% |
| PineBridge Investments Asia Ltd.as of 30 Jun 2024 | 480.86k | 1.23% |
